2Carolyn L. Westhoff. Current assessment of the use of intrauterine devices[J]. Journal of nurse-Midwifery, 1996, 41(3): 218-219.
3Michel Thiery. Intrauterine contraception: from silver ring to intrauterine contraceptive implant[J]. European Journal ofObstetries & Gynecology andReproductive Biology, 2000, 90: 145-152.
4Zipper ZA, Tatum HJ, Pastene L, et al. Metalfic copper as an intrauterinecontraceptive adjunct to the "T" device[J]. Am J Obstet and Gynecol, 1969, 105:1274-1278.
5Zipper J, Medal M, Prager R. Suppression of fertility by intrauterine copper and zincin rabbits: a new approach to intrauterine contraception[J].Am J Obstet Gynecol, 1969,105: 529-534.
6Damrong Reinprayoon, Surasak Taneepanichskul, Somchai Niruthisard, et al.Uterine Histopathologic Changes After Cu-Fix Intrauterine Device Insertion[J].Contraception, 1999, 59: 63-65.
7Wildemeersch D, Batar I, Webb A, et al. GyneFix: the frameless implant for interval, emergency and postabortal contraception. Anupdate[J]. Br J Family Planning, 1999, 24: 149-159.
8Scommegna A, Pandya GN, Christ M, et al. Intrauterine administration ofprogesterone by a slow releasing device[J]. Fertil Steril, 1970, 21: 201-205.
9Nilsson CG, Luukkainen T, Arko H. Endometrial morphology of women using ad-norgestrel-releasing intrauterine device[J]. Fertil Steril, 1978, 29:397-401.
5Nygren KG, Rybo G. Prostaglandins and menorrhagia. Acta Obstet Gynecol Scand, Suppl, 1983,113:101-103.
6Toppozada M. Treatment of increased menstrual blood loss in IUD users. Contraception, 1987,36:145-157.
7Gopal KM, Adriana RS, Larry WT, et al. Lysophos-phatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J Lipid Res,2001,42:1 430-7.
8Liu YX, Liu K, Feng Q, et al. Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I are coordinately expressed during ovulation in the rhesus monkey. Endocrinology, 2004, 145(4) :1 767-75.
9Mora N, Cano E, Morn EM, et al. Influence of pH and oxygen on copper corrosion in stimulated uterine fluid. Biomaterials,2002, 23(3): 667-71
10Gleeson N, Devitt M, Sheppard BL, et al. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol,1993,100(2): 768-71
